Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966221405> ?p ?o ?g. }
- W1966221405 endingPage "2060" @default.
- W1966221405 startingPage "2055" @default.
- W1966221405 abstract "Three different recombinant interferon beta (IFNbeta) preparations are currently available for the treatment of MS, two IFNbeta-1a products (Rebif and Avonex) and one IFNbeta-1b product (Betaferon). These products differ with respect to the recommended dose, the dosage regimen, and the injection route. This study compared the relative biologic activity of these three products in vitro and in vivo.Blood samples were collected from 237 patients with MS (170 on IFNbeta therapy and 67 control subjects receiving no therapy). Samples with neutralizing antibodies were excluded. Levels of the antiviral protein MxA and soluble vascular cell adhesion molecule-1 (sVCAM) in the four groups were measured by ELISA. In the in vitro investigation, untreated blood was incubated for 24 hours with increasing concentrations of the three IFNs from a dose of 1 IU/mL to 1000 IU/mL, after which levels of MxA were measured.A difference between the groups was observed in vitro, with a significant change from baseline in MxA levels being observed at 10 IU for Betaferon compared with 100 IU for Rebif and Avonex. However, this might be due to the different methods used for the determination of IU by the manufacturers. At the single-dose level there were no significant differences between IFNbeta preparations. In vivo, there were significantly different levels of MxA in the four groups. In the Betaferon group, the median value for MxA was 2.29 ng/105 peripheral blood leukocytes (PBL), compared with 1.00 ng/105 PBL for Rebif, 0.57 ng/105 PBL for Avonex, and 0.14 ng/105 PBL for the control group. Some significant differences between the groups were also apparent with respect to levels of sVCAM, which were higher with Betaferon than with Rebif.IFNbeta-1b induces higher levels of the above markers of IFNbeta bioactivity than either of the two IFNbeta-1a preparations. Moreover, there is a less striking difference between the two IFNbeta-1a preparations in favor of subcutaneous IFNbeta-1a." @default.
- W1966221405 created "2016-06-24" @default.
- W1966221405 creator A5006580333 @default.
- W1966221405 creator A5008414831 @default.
- W1966221405 creator A5055411908 @default.
- W1966221405 creator A5056983959 @default.
- W1966221405 creator A5060017986 @default.
- W1966221405 creator A5060641186 @default.
- W1966221405 creator A5079666418 @default.
- W1966221405 creator A5084903816 @default.
- W1966221405 date "2000-06-13" @default.
- W1966221405 modified "2023-10-16" @default.
- W1966221405 title "A comparative study of the relative bioavailability of different interferon beta preparations" @default.
- W1966221405 cites W1523528013 @default.
- W1966221405 cites W1975995030 @default.
- W1966221405 cites W1991884672 @default.
- W1966221405 cites W2004723648 @default.
- W1966221405 cites W2006218745 @default.
- W1966221405 cites W2031907187 @default.
- W1966221405 cites W2036364847 @default.
- W1966221405 cites W2041686092 @default.
- W1966221405 cites W2051606447 @default.
- W1966221405 cites W2123226439 @default.
- W1966221405 cites W2139367012 @default.
- W1966221405 cites W2148674563 @default.
- W1966221405 cites W2164542304 @default.
- W1966221405 cites W2169098250 @default.
- W1966221405 cites W232279843 @default.
- W1966221405 cites W2485483395 @default.
- W1966221405 cites W4210548604 @default.
- W1966221405 cites W4244801936 @default.
- W1966221405 doi "https://doi.org/10.1212/wnl.54.11.2055" @default.
- W1966221405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10851362" @default.
- W1966221405 hasPublicationYear "2000" @default.
- W1966221405 type Work @default.
- W1966221405 sameAs 1966221405 @default.
- W1966221405 citedByCount "78" @default.
- W1966221405 countsByYear W19662214052012 @default.
- W1966221405 countsByYear W19662214052013 @default.
- W1966221405 countsByYear W19662214052014 @default.
- W1966221405 countsByYear W19662214052016 @default.
- W1966221405 countsByYear W19662214052017 @default.
- W1966221405 countsByYear W19662214052018 @default.
- W1966221405 countsByYear W19662214052022 @default.
- W1966221405 crossrefType "journal-article" @default.
- W1966221405 hasAuthorship W1966221405A5006580333 @default.
- W1966221405 hasAuthorship W1966221405A5008414831 @default.
- W1966221405 hasAuthorship W1966221405A5055411908 @default.
- W1966221405 hasAuthorship W1966221405A5056983959 @default.
- W1966221405 hasAuthorship W1966221405A5060017986 @default.
- W1966221405 hasAuthorship W1966221405A5060641186 @default.
- W1966221405 hasAuthorship W1966221405A5079666418 @default.
- W1966221405 hasAuthorship W1966221405A5084903816 @default.
- W1966221405 hasConcept C126322002 @default.
- W1966221405 hasConcept C150903083 @default.
- W1966221405 hasConcept C181389837 @default.
- W1966221405 hasConcept C185592680 @default.
- W1966221405 hasConcept C202751555 @default.
- W1966221405 hasConcept C203014093 @default.
- W1966221405 hasConcept C207001950 @default.
- W1966221405 hasConcept C2776178377 @default.
- W1966221405 hasConcept C2908698914 @default.
- W1966221405 hasConcept C2994247566 @default.
- W1966221405 hasConcept C55493867 @default.
- W1966221405 hasConcept C71924100 @default.
- W1966221405 hasConcept C86803240 @default.
- W1966221405 hasConcept C98274493 @default.
- W1966221405 hasConceptScore W1966221405C126322002 @default.
- W1966221405 hasConceptScore W1966221405C150903083 @default.
- W1966221405 hasConceptScore W1966221405C181389837 @default.
- W1966221405 hasConceptScore W1966221405C185592680 @default.
- W1966221405 hasConceptScore W1966221405C202751555 @default.
- W1966221405 hasConceptScore W1966221405C203014093 @default.
- W1966221405 hasConceptScore W1966221405C207001950 @default.
- W1966221405 hasConceptScore W1966221405C2776178377 @default.
- W1966221405 hasConceptScore W1966221405C2908698914 @default.
- W1966221405 hasConceptScore W1966221405C2994247566 @default.
- W1966221405 hasConceptScore W1966221405C55493867 @default.
- W1966221405 hasConceptScore W1966221405C71924100 @default.
- W1966221405 hasConceptScore W1966221405C86803240 @default.
- W1966221405 hasConceptScore W1966221405C98274493 @default.
- W1966221405 hasIssue "11" @default.
- W1966221405 hasLocation W19662214051 @default.
- W1966221405 hasLocation W19662214052 @default.
- W1966221405 hasOpenAccess W1966221405 @default.
- W1966221405 hasPrimaryLocation W19662214051 @default.
- W1966221405 hasRelatedWork W1965016416 @default.
- W1966221405 hasRelatedWork W1999407296 @default.
- W1966221405 hasRelatedWork W2032925164 @default.
- W1966221405 hasRelatedWork W2054843986 @default.
- W1966221405 hasRelatedWork W2379311614 @default.
- W1966221405 hasRelatedWork W2411073575 @default.
- W1966221405 hasRelatedWork W2411508074 @default.
- W1966221405 hasRelatedWork W2753834235 @default.
- W1966221405 hasRelatedWork W4237802932 @default.
- W1966221405 hasRelatedWork W120488427 @default.
- W1966221405 hasVolume "54" @default.
- W1966221405 isParatext "false" @default.